• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Tokyo Startup Bisu Raises $3.2M for ‘Lab-On-A-Chip’ Urine and Saliva Analyzer

by Fred Pennic 10/07/2021 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
Tokyo Startup Bisu Raises $3.2M for 'Lab-On-A-Chip' Urine and Saliva Analyzer

What You Should Know:

– Bisu, Inc., a  Tokyo-based digital health startup that helps people improve their health and wellness through lab-grade testing at home, today announced ­$3.2M in seed funding led by Korean biotech investor QUAD, with participation from ASI­CS Ventures Corporation, 15th Rock Ventures, Pacifico Investments, and SOSV.

– The funding will enable Bisu to bring to market Bisu Body Coach, a portable “home health lab” for personalized nutrition and lifestyle advice through easy, accurate urine and saliva testing. Bisu also reached an agreement with ASICS Corporation to collaborate on health and fitness service initiatives.

Bisu Body Coach: Bringing the Lab to Your Home

Bisu Body Coach consists of a disposable test stick and a reader that syncs with a companion smartphone app. The microfluidic “lab-on-a-chip” technology used in the test stick enables reliable, precise and automated measurements of a wide range of biomarkers in just two minutes. The app provides feedback on key nutrition indicators such as hydration, minerals and vitamins, and recommendations are personalized based on the user’s goals, dietary preferences, activity, sleep and weight. 

Bisu Body Coach Availability & Pipeline

Bisu Body Coach is currently in beta, with a pipeline of additional test sticks covering training intensity, hormones, and pet and baby health. Bisu and ASICS will work together on future initiatives aimed to enhance personal health and athletic performance. ASICS’ investment follows Bisu’s victory in the U.S. Sports & Fitness Industry Association’s startup competition — one of the industry’s major events for which more than 100 sports and fitness executives served as judges.

“This funding is a major vote of confidence from a group of investors who are both tech-savvy, consumer-focused and globally minded,” says Daniel Maggs, Co-founder & CEO at Bisu. “We are delighted to announce our collaboration with ASICS. ASICS shares our passion for making beautiful yet scientifically rigorous products in the spirit of Japanese craftsmanship, yet is also a modern, globally-recognized brand,” says Wojciech Bula, PhD, Co-founder & CTO.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

Aligning IT & Clinical Teams: How to Reduce Friction and Improve Communication

Most-Read

Francisco Partners to Acquire Weave in $650M Take-Private Deal

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Redesign Health Study: 71% of Health Systems Adopt an "Epic-First" AI Purchasing Strategy

Redesign Health Study: 71% of Health Systems Adopt an “Epic-First” AI Purchasing Strategy

iRhythm to Acquire VitalConnect for $287.5M to Build Broad Cardiac Intelligence Platform

M&A: iRhythm to Acquire VitalConnect for $287.5M to Build Broad Cardiac Intelligence Platform

CB Insights Q2 2026 State of Digital Health Report: Fewest Deals in Over a Decade as Median Sizes Rise

CB Insights Q2 2026 State of Digital Health Report: Fewest Deals in Over a Decade as Median Sizes Rise

mount-sinai-launches-epic-chart-with-art-nursing-ambient-ai

Mount Sinai Medical Center Extends Epic’s Ambient AI to Inpatient Nursing

M&A: Tempus AI to Acquire Personalis for $1.5B to Expand Precision Oncology and MRD Monitoring

M&A: Tempus AI to Acquire Personalis for $1.5B to Expand Precision Oncology and MRD Monitoring

Why Brain Health Is Entering Its Infrastructure Era

Brain Health’s Infrastructure Era: Proving Clinical Outcomes with Integrated Neuromotor Tracking

Why Catholic Health Inked a $500M Care Alliance with GE HealthCare to Automate Outpatient Triage

Catholic Health Inks $500M Care Alliance with GE HealthCare to Automate Outpatient Triage

KLAS Global HIT Trends 2026 Report: Artificial Intelligence Becomes the Top Investment Priority

KLAS Global HIT Trends 2026 Report: Artificial Intelligence Becomes the Top Investment Priority

Secondary Sidebar

Footer

Company

  • About Us
  • 2026 Editorial Calendar
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2026. HIT Consultant Media. All Rights Reserved. Privacy Policy |